Journal of Surgical Oncology · 2017 · 27 citations · 20 references
MedicineOncologySurgeryBiomedical ImagingBreast OncologyDiagnostic ImagingBreast Cancer SurgeryBreast SurgeryLymph Node PathologySentinel Lymph Node BiopsySentinel Lymph Node ImagingSentinel Lymph Node MappingAxillary Sentinel Lymph Node BiopsyBreast Cancer Sentinel Node MappingIndocyanine Green MappingReverse MappingSentinel Lymph Node IdentificationSentinel Node-positive Breast CancerSentinel NodesTechnetium-99m Labeled Colloid Imaging
BACKGROUND: Sentinel lymph node (SLN) resection is imperative for breast cancer staging. Axillary reverse mapping (ARM) can preserve arm draining nodes and lymphatics during surgery. ARM is generally performed with isosulfan blue (ISB), restricting its use for concurrent SLN biopsy. Indocyanine green (ICG) could serve as an alternative to ISB for ARM procedures. METHODS: TcSc, TSC). ISB and ICG were injected in the upper arm. Blue-stained lymphatics or nodes were visualized in the axilla; ICG was identified using the SPY Elite® system. RESULTS: Twenty-three patients underwent SLN biopsy with or without axillary node dissection and ARM procedures. Twenty of these patients had at least one hot node; 12 patients had SLNs that were only hot, 6 hot/blue/fluorescent, and 2 hot/fluorescent. Overall, crossover of ARM agents with SLNs occurred in 8 cases. Inspection of the axillary cavity after SLN biopsy revealed fluorescent lymphatics and nodes remaining in 14 and 7 patients, respectively. Blue lymphatics and blue nodes were detected in fewer cases. CONCLUSION: Nearly one-third of patients showed crossover between breast and arm draining nodes, which provides insight as to why some patients develop lymphedema symptoms after SLN biopsy. ICG and ISB identify similar numbers of SLNs. As such ICG could substitute for ISB in ARM procedures.
20
Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer
Armando E. Giuliano, Daniel Kirgan, Julia Guenther et al. · Annals of Surgery · 1994 · 2.9K citations
The Sentinel Node in Breast Cancer — A Multicenter Validation Study
David N. Krag, Donald L. Weaver, Takamaru Ashikaga et al. · New England Journal of Medicine · 1998 · 2K citations · Full text
David N. Krag, Stewart Anderson, Thomas B. Julian et al. · The Lancet Oncology · 2010 · 1.9K citations · Full text
Mila Donker, Geertjan van Tienhoven, Marieke E. Straver et al. · The Lancet Oncology · 2014 · 1.8K citations · Full text